Virus-like particles activate type I interferon pathways to facilitate post-exposure protection against Ebola virus infection.

Virus-like particles activate type I interferon pathways to facilitate post-exposure protection against Ebola virus infection.

Ebola virus (EBOV) causes a severe hemorrhagic disease with high fatality. Virus-like particles (VLPs) are a promising vaccine candidate against EBOV. We recently showed that VLPs protect mice from lethal EBOV infection when given before or after viral infection. To elucidate pathways through which...

Full description

Bibliographic Details
Main Authors: Natarajan Ayithan, Steven B Bradfute, Scott M Anthony, Kelly S Stuthman, Sina Bavari, Mike Bray, Keiko Ozato
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0118345

Internet

https://doi.org/10.1371/journal.pone.0118345

Similar Items